Therefore, we will explore the level of OPA1 gene expression in pan-cancer, its mutation types, and the relationship of these alterations with patient prognosis and immune microenvironment, as well as the molecular mechanisms that may be involved. This evidence concerns the gene OPA1 and cancer.